Income StatementBalance SheetCash FlowSegments
Cigna logo

Cigna Balance Sheet Statement

Assets, liabilities, and shareholders' equity

Cigna holds $153.27B in total assets. Cash and equivalents total $7.0B. The current ratio is 0.818. Based on the Q1 2026 filing.

Total Assets$153.27BTotal Stockholders Equity$42.2BCash And Equivalents$7.0BTotal Current Assets$43.0BTotal Current Liabilities$52.6B
Latest FilingQ1 2026
Report Date2026-04-30
Market Cap$75.7B
P/E Ratio12.21
ROE15.05%

Current Liabilities

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Accounts payable$9.3B$9.1B$9.9B$9.3B$10.7B$9.9B
Liabilities held for sale$2.4B$0.0$0.0$0.0$0.0—
Total current liabilities$58.0B$55.7B$56.8B$56.5B$56.3B$52.6B

Current Assets

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Accounts receivable, net$24.2B$26.9B$31.1B$31.7B$28.8B$26.6B
Assets held for sale$7.0B$0.0$0.0$0.0$0.0—
Cash and cash equivalents$7.6B$8.3B$4.3B$6.0B$7.7B$7.0B
Other current assets$2.7B$2.4B$2.5B$2.5B$3.0B$2.7B
Inventories$6.7B$5.2B$6.0B$5.6B$7.3B$5.8B
Total current assets$48.9B$43.6B$44.7B$46.7B$47.8B$43.0B

Equity

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Accumulated other comprehensive income (loss)-$2.3B-$2.6B-$2.8B-$2.8B-$2.8B-$3.6B
Additional paid-in capital$31.3B$31.4B$31.6B$31.7B$31.8B$31.9B
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively$4.0M$4.0M$4.0M$4.0M$4.0M$4.0M
Treasury Stock, Value$31.4B$33.1B$34.1B$34.1B$35.1B$35.2B
Retained earnings$43.5B$44.4B$45.6B$47.0B$47.9B$49.1B
Total liabilities and stockholders' equity$155.9B$150.7B$151.7B$157.9B$157.9B$153.3B
Total stockholders' equity$41.0B$40.2B$40.2B$41.8B$41.7B$42.2B

Non-Current Assets

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Deferred Tax Assets and Other Non-Current Assets$2.8B$3.0B$2.9B$3.4B$2.9B$3.3B
Goodwill$44.4B$44.4B$44.4B$44.9B$44.9B$45.5B
Other intangible assets—net$29.4B$29.0B$28.7B$29.0B$28.6B$27.3B
Investments$15.1B$15.4B$15.7B$18.5B$18.5B$18.9B
Other non-current assets$2.8B$3.0B$2.9B$3.4B$2.9B$3.3B
Property, plant and equipment, net$3.7B$3.7B$3.6B$3.7B$3.7B$3.7B
Reinsurance recoverables$4.4B$4.4B$4.3B$4.2B$4.1B$4.1B
Separate account assets$7.3B——$7.6B$7.5B$7.5B
Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84)$665.0M$727.0M$813.0M$883.0M$1.1B$812.0M
Software and Technology Licenses, Net$2.8B$3.0B$2.9B$3.4B$2.9B$3.3B
Total assets$155.9B$150.7B$151.7B$157.9B$157.9B$153.3B

Non-Current Liabilities

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Separate account liabilities$7.3B$7.3B$7.4B$7.6B$7.5B$7.5B
Long-Term Debt and Finance Lease Obligations$28.9B$26.5B$26.5B$30.9B$30.9B$29.4B
Accrued expenses and other liabilities$9.4B$8.0B$7.1B$7.7B$9.0B$9.0B
Current insurance and contractholder liabilities$5.4B$6.0B$6.0B$6.0B$5.7B$6.5B
Non-current insurance and contractholder liabilities$10.3B$10.3B$10.2B$10.1B$9.9B$9.8B
Pharmacy and other service costs payable$28.5B$28.6B$29.5B$30.3B$30.3B$25.8B
Other non-current liabilities$3.2B$3.6B$3.7B$3.9B$4.2B$4.8B
Total liabilities$114.6B$110.2B$111.2B$115.9B$116.0B$110.8B

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Short-term debt and current portion of long-term debt$3.0B$4.0B$4.3B$3.1B$592.0M$1.5B
Deferred income taxes$7.0B$6.9B$6.8B$7.0B$7.1B$6.9B
Long-Term Debt and Lease Obligation$28.9B$26.5B$26.5B$30.9B$30.9B$29.4B
Noncontrolling interests in subsidiaries$210.0M$188.0M$216.0M$209.0M$161.0M$232.0M